Gastric cancer is one of the most common malignant tumors in the world.Its incidence ranks fifth among all malignant tumors worldwide and is the third leading cause of death among cancer patients.Surgery is currently considered to be the only radical treatment.However,the low rate of early diagnosis means that most patients have an advanced-stage disease at diagnosis which lost the chance of surgery.Therefore,the main treatment for advanced gastric cancer includes chemotherapy,targeted therapy,immunotherapy.The purpose of this study is to review the transition and current patterns of drug therapy for advanced gastric cancer and to provide assistance for subsequent clinical studies in advanced gastric cancer.
展开▼
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing) of Early Drug Development Center University Cancer Hospital&Institute 100142;
School of Basic Medical Sciences Medical University 100069;
机译:Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and s-1 (DCs therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes